Aimei Health Technology Co., Ltd. (AFJK)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
AFJK Stock: 5 Things to Know as a United Hydrogen SPAC Merger Takes Shape
Aimei Health Technology (NASDAQ: AFJK ) stock is surprisingly down today despite news that the blank-check company will merge with United Hydrogen Group in a special purpose acquisition company (SPAC) merger worth roughly $1.6 billion. Indeed, United Hydrogen will go public on the Nasdaq through a very fashionable SPAC merger with Aimei, with a new ticker to boot.
Aimei Health Technology Co., Ltd. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Daniel L. Lippincott Karpus Management Inc. | 77,125 | $788,581.53 | $897,735 | $109,153.47 | 13.84% |
| BO Brian Oliveira Clear Street Group Inc. | 83,337 | $2.12M | $971,709.42 | -$1.15M | -54.12% |
| MA Marie-Andree Alain Federation des caisses Desjardins du Quebec | 185 | $4,533 | $2,150.48 | -$2,382.52 | -52.56% |
Aimei Health Technology Co., Ltd. (AFJK) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Aimei Health Technology Co., Ltd. ever had a stock split?
Aimei Health Technology Co., Ltd. Profile
| Trading Companies & Distributors Industry | Industrials Sector | Junheng Xie CEO | NASDAQ (NMS) Exchange | G01341109 CUSIP |
| US Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Aimei Health Technology Co., Ltd is a company in its nascent stage, focusing on the healthcare sector. Established in 2023, the company is strategically positioned in New York, New York, a hub that provides access to a vast network of potential business collaborations within the biopharmaceutical, medical technology/devices, diagnostics, and services sectors. Currently without significant operations, Aimei Health Technology is in the phase of scouting for viable business opportunities. It aims to grow by engaging in various strategic business transactions such as mergers, share exchanges, asset acquisitions, share purchases, recapitalizations, reorganizations, or other similar business combinations. Through these activities, the company plans to establish a footprint in the healthcare industry, targeting to become a key player by acquiring businesses within the biopharmaceutical, medical technology or device industries, as well as diagnostics and other healthcare-related services.
Products and Services
As of its inception, Aimei Health Technology Co., Ltd has not launched any products or services, given its current focus on identifying and executing strategic business combinations. However, the company outlines its future interest in the following areas:
- Biopharmaceuticals - Aimei intends to explore opportunities within the biopharmaceutical sector, a dynamic and rapidly growing area focused on medical drugs produced using biotechnology. They plan to invest in or acquire companies specializing in innovative drug development, aiming to bring novel treatments to market.
- Medical Technology and Devices - The company shows a keen interest in the medical technology and devices sector. This includes businesses involved in the design, manufacture, and sale of medical devices and equipment. Aimei seeks to support or acquire companies leading in technology-driven solutions that improve patient care and health outcomes.
- Diagnostics and Other Services - Essential to healthcare, diagnostic services include various tests and analyses to aid in the detection, diagnosis, and management of diseases. Aimei Health Technology is looking into businesses that offer cutting-edge diagnostic tools and services, along with other essential healthcare services that can enhance efficiency and effectiveness in patient care management.
